{
  "id": "5fcb0d6a-d280-3fc6-8f6e-b330aabc207d",
  "webUrl": "http://ftalphaville.ft.com/marketslive/2018-03-28/",
  "title": "Wednesday, 28th March, 2018",
  "alternativeTitles": {},
  "provenance": [
    "https://api.ft.com/internalcontent/5fcb0d6a-d280-3fc6-8f6e-b330aabc207d"
  ],
  "byline": "Bryce Elder",
  "publishedDate": "2018-03-28T10:07:31.000Z",
  "firstPublishedDate": "2018-03-28T10:07:31.000Z",
  "publishReference": "tid_yrve6mpeip_carousel_1558344488",
  "curatedRelatedContent": [],
  "containedIn": [],
  "canBeDistributed": "yes",
  "canBeSyndicated": "verify",
  "comments": {
    "enabled": true
  },
  "standout": {
    "editorsChoice": false,
    "exclusive": false,
    "scoop": false
  },
  "realtime": true,
  "originatingParty": "FT",
  "_lastUpdatedDateTime": "2019-12-11T15:05:52.634Z",
  "_lastUpdatedVersion": "7e31a715ef987f4138810700061579e58b572501",
  "type": "article",
  "accessLevel": "registered",
  "topper": {},
  "url": "http://ftalphaville.ft.com/marketslive/2018-03-28/",
  "relativeUrl": "http://ftalphaville.ft.com/marketslive/2018-03-28/",
  "_editorialComponents": [],
  "openingHTML": "<p>Live markets commentary from FT.com</p>",
  "annotations": [
    {
      "FIGI": "BBG000BFYPV6",
      "apiUrl": "http://api.ft.com/organisations/8d526900-a952-4904-8534-36c020dcffce",
      "directType": "http://www.ft.com/ontology/organisation/Organisation",
      "id": "8d526900-a952-4904-8534-36c020dcffce",
      "predicate": "http://www.ft.com/ontology/annotation/majorMentions",
      "prefLabel": "Shire PLC",
      "type": "ORGANISATION",
      "types": [
        "http://www.ft.com/ontology/core/Thing",
        "http://www.ft.com/ontology/concept/Concept",
        "http://www.ft.com/ontology/organisation/Organisation"
      ],
      "preposition": "on",
      "url": "https://www.ft.com/stream/8d526900-a952-4904-8534-36c020dcffce",
      "relativeUrl": "/stream/8d526900-a952-4904-8534-36c020dcffce"
    },
    {
      "apiUrl": "http://api.ft.com/brands/89d15f70-640d-11e4-9803-0800200c9a66",
      "directType": "http://www.ft.com/ontology/product/Brand",
      "id": "89d15f70-640d-11e4-9803-0800200c9a66",
      "predicate": "http://www.ft.com/ontology/classification/isClassifiedBy",
      "prefLabel": "FT Alphaville",
      "type": "BRAND",
      "types": [
        "http://www.ft.com/ontology/core/Thing",
        "http://www.ft.com/ontology/concept/Concept",
        "http://www.ft.com/ontology/classification/Classification",
        "http://www.ft.com/ontology/product/Brand"
      ],
      "preposition": "from",
      "url": "https://www.ft.com/stream/89d15f70-640d-11e4-9803-0800200c9a66",
      "relativeUrl": "/stream/89d15f70-640d-11e4-9803-0800200c9a66"
    },
    {
      "apiUrl": "http://api.ft.com/things/6da31a37-691f-4908-896f-2829ebe2309e",
      "directType": "http://www.ft.com/ontology/Genre",
      "id": "6da31a37-691f-4908-896f-2829ebe2309e",
      "predicate": "http://www.ft.com/ontology/classification/isClassifiedBy",
      "prefLabel": "Opinion",
      "type": "GENRE",
      "types": [
        "http://www.ft.com/ontology/core/Thing",
        "http://www.ft.com/ontology/concept/Concept",
        "http://www.ft.com/ontology/classification/Classification",
        "http://www.ft.com/ontology/Genre"
      ],
      "preposition": "",
      "url": "https://www.ft.com/opinion",
      "relativeUrl": "/opinion"
    },
    {
      "apiUrl": "http://api.ft.com/things/c91b1fad-1097-468b-be82-9a8ff717d54c",
      "directType": "http://www.ft.com/ontology/Topic",
      "id": "c91b1fad-1097-468b-be82-9a8ff717d54c",
      "predicate": "http://www.ft.com/ontology/classification/isPrimarilyClassifiedBy",
      "prefLabel": "Markets",
      "type": "TOPIC",
      "types": [
        "http://www.ft.com/ontology/core/Thing",
        "http://www.ft.com/ontology/concept/Concept",
        "http://www.ft.com/ontology/Topic"
      ],
      "preposition": "on",
      "url": "https://www.ft.com/markets",
      "relativeUrl": "/markets"
    },
    {
      "apiUrl": "http://api.ft.com/people/602c702b-31fe-4116-a203-747c7c737eb7",
      "directType": "http://www.ft.com/ontology/person/Person",
      "id": "602c702b-31fe-4116-a203-747c7c737eb7",
      "predicate": "http://www.ft.com/ontology/annotation/hasAuthor",
      "prefLabel": "Bryce Elder",
      "type": "PERSON",
      "types": [
        "http://www.ft.com/ontology/core/Thing",
        "http://www.ft.com/ontology/concept/Concept",
        "http://www.ft.com/ontology/person/Person"
      ],
      "preposition": "from",
      "url": "https://www.ft.com/markets/bryce-elder",
      "relativeUrl": "/markets/bryce-elder"
    }
  ],
  "genreConcept": {
    "apiUrl": "http://api.ft.com/things/6da31a37-691f-4908-896f-2829ebe2309e",
    "directType": "http://www.ft.com/ontology/Genre",
    "id": "6da31a37-691f-4908-896f-2829ebe2309e",
    "predicate": "http://www.ft.com/ontology/classification/isClassifiedBy",
    "prefLabel": "Opinion",
    "type": "GENRE",
    "types": [
      "http://www.ft.com/ontology/core/Thing",
      "http://www.ft.com/ontology/concept/Concept",
      "http://www.ft.com/ontology/classification/Classification",
      "http://www.ft.com/ontology/Genre"
    ],
    "preposition": "",
    "url": "https://www.ft.com/opinion",
    "relativeUrl": "/opinion"
  },
  "brandConcept": {
    "apiUrl": "http://api.ft.com/brands/89d15f70-640d-11e4-9803-0800200c9a66",
    "directType": "http://www.ft.com/ontology/product/Brand",
    "id": "89d15f70-640d-11e4-9803-0800200c9a66",
    "predicate": "http://www.ft.com/ontology/classification/isClassifiedBy",
    "prefLabel": "FT Alphaville",
    "type": "BRAND",
    "types": [
      "http://www.ft.com/ontology/core/Thing",
      "http://www.ft.com/ontology/concept/Concept",
      "http://www.ft.com/ontology/classification/Classification",
      "http://www.ft.com/ontology/product/Brand"
    ],
    "preposition": "from",
    "url": "https://www.ft.com/stream/89d15f70-640d-11e4-9803-0800200c9a66",
    "relativeUrl": "/stream/89d15f70-640d-11e4-9803-0800200c9a66"
  },
  "authorConcepts": [
    {
      "apiUrl": "http://api.ft.com/people/602c702b-31fe-4116-a203-747c7c737eb7",
      "directType": "http://www.ft.com/ontology/person/Person",
      "id": "602c702b-31fe-4116-a203-747c7c737eb7",
      "predicate": "http://www.ft.com/ontology/annotation/hasAuthor",
      "prefLabel": "Bryce Elder",
      "type": "PERSON",
      "types": [
        "http://www.ft.com/ontology/core/Thing",
        "http://www.ft.com/ontology/concept/Concept",
        "http://www.ft.com/ontology/person/Person"
      ],
      "preposition": "from",
      "url": "https://www.ft.com/markets/bryce-elder",
      "relativeUrl": "/markets/bryce-elder"
    }
  ],
  "design": {
    "theme": "basic",
    "layout": "default"
  },
  "displayConcept": {
    "apiUrl": "http://api.ft.com/things/c91b1fad-1097-468b-be82-9a8ff717d54c",
    "directType": "http://www.ft.com/ontology/Topic",
    "id": "c91b1fad-1097-468b-be82-9a8ff717d54c",
    "predicate": "http://www.ft.com/ontology/classification/isPrimarilyClassifiedBy",
    "prefLabel": "Markets",
    "type": "TOPIC",
    "types": [
      "http://www.ft.com/ontology/core/Thing",
      "http://www.ft.com/ontology/concept/Concept",
      "http://www.ft.com/ontology/Topic"
    ],
    "preposition": "on",
    "url": "https://www.ft.com/markets",
    "relativeUrl": "/markets",
    "isDisplayTag": false
  },
  "teaser": {
    "id": "5fcb0d6a-d280-3fc6-8f6e-b330aabc207d",
    "url": "http://ftalphaville.ft.com/marketslive/2018-03-28/",
    "relativeUrl": "http://ftalphaville.ft.com/marketslive/2018-03-28/",
    "type": "article",
    "indicators": {
      "isColumn": true,
      "isOpinion": true,
      "isScoop": false,
      "isExclusive": false,
      "isEditorsChoice": false,
      "accessLevel": "registered"
    },
    "metaPrefixText": "FT Alphaville",
    "metaSuffixText": null,
    "metaLink": {
      "id": "602c702b-31fe-4116-a203-747c7c737eb7",
      "predicate": "http://www.ft.com/ontology/annotation/hasAuthor",
      "prefLabel": "Bryce Elder",
      "type": "PERSON",
      "url": "https://www.ft.com/markets/bryce-elder",
      "relativeUrl": "/markets/bryce-elder"
    },
    "metaAltLink": {
      "id": "c91b1fad-1097-468b-be82-9a8ff717d54c",
      "predicate": "http://www.ft.com/ontology/classification/isPrimarilyClassifiedBy",
      "prefLabel": "Markets",
      "type": "TOPIC",
      "url": "https://www.ft.com/markets",
      "relativeUrl": "/markets"
    },
    "title": "Markets Live: Wednesday, 28th March, 2018",
    "altStandfirst": null,
    "publishedDate": "2018-03-28T10:07:31.000Z",
    "firstPublishedDate": "2018-03-28T10:07:31.000Z",
    "image": {},
    "parentTheme": null
  },
  "contentStats": {
    "wordCount": 1,
    "paragraphs": 0,
    "relatedBoxes": 0,
    "pullQuotes": 0,
    "pullQuotesWithImages": 0,
    "bigNumbers": 0,
    "images": 0,
    "responsiveImages": 0,
    "graphics": 0,
    "audio": 0,
    "videos": 0,
    "internalVideos": 0,
    "externalVideos": 0,
    "subheadings": 0,
    "curatedRecommended": 0,
    "layouts": 0,
    "layoutSlots": 0,
    "infoBox": 0,
    "tables": 0,
    "timelines": 0,
    "singleArticleRecommendations": 0,
    "sentiment": 0,
    "scoreGraphicVolume": 0,
    "scoreGraphicDensity": 0,
    "scorePictureVolume": 0,
    "scorePictureDensity": 0
  },
  "isMarketsLive": true,
  "av2WebUrl": "/marketslive/2018-03-28/",
  "bodyHTML": "<div class=\"webchat-closed-content\"><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:07:58.000Z\" title=\"Wed Mar 28 2018 10:07:58 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:07:58 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:07 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522231693\" data-mid=\"1413995\" data-rawmessage=\"Late to start ... Sorry. You can probably guess why.\" id=\"webchat-msg-1413995\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:08am</span></span><div class=\"messagebody\"><p>Late to start ... Sorry. You can probably guess why.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Lemmy</span>\n\t\t\t\t\t\t\t\tOhayu gozaimasu / top of the morning to all\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Peace and Love</span>\n\t\t\t\t\t\t\t\tBonjour\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\tHOla - Shired at last\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Soundbuy</span>\n\t\t\t\t\t\t\t\tMorning\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\tShire?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">VV75</span>\n\t\t\t\t\t\t\t\tthe daytraders had the right idea, for once\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Alchemy30</span>\n\t\t\t\t\t\t\t\tCrikey !!\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\tHola @BE\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522231788\" data-mid=\"1413996\" data-rawmessage=\"Here&apos;s what we wrote on Monday .....\" id=\"webchat-msg-1413996\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:09am</span></span><div class=\"messagebody\"><p>Here&apos;s what we wrote on Monday .....</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Ashurbanipal</span>\n\t\t\t\t\t\t\t\tAny word from Greg Clark yet?\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522231791\" data-mid=\"1413997\" data-rawmessage=\"https://i.imgur.com/RtOr15N.png\" id=\"webchat-msg-1413997\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:09am</span></span><div class=\"messagebody\"><p><img class=\"picture\" src=\"https://www.ft.com/__origami/service/image/v2/images/raw/%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fi.imgur.com%252FRtOr15N.png%3Fsource%3DAlphaville%26width%3D675%26fit%3Dscale-down?source=Alphaville\"></p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:09:40.000Z\" title=\"Wed Mar 28 2018 10:09:40 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:09:40 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:09 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522231795\" data-mid=\"1413998\" data-rawmessage=\"Heh.\" id=\"webchat-msg-1413998\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:09am</span></span><div class=\"messagebody\"><p>Heh.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">jaws</span>\n\t\t\t\t\t\t\t\tAny  price mention  on SHP  talk  ?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">RA</span>\n\t\t\t\t\t\t\t\tyesterday was very painful for me\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Grouchmonkey</span>\n\t\t\t\t\t\t\t\tMorning, morning\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@BE I&apos;ve been working the phones and can weigh with thoughts when you are ready. Our fuller story is coming within the next 30 min or so.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522231837\" data-mid=\"1413999\" data-rawmessage=\"(Apologies for @Flaneur in the middle of that. Apologies also for Flaneur more generally.)\" id=\"webchat-msg-1413999\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:10am</span></span><div class=\"messagebody\"><p>(Apologies for @Flaneur in the middle of that. Apologies also for Flaneur more generally.)</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522231840\" data-mid=\"1414000\" data-rawmessage=\"https://ftalphaville.ft.com/marketslive/2018-03-26/\" id=\"webchat-msg-1414000\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:10am</span></span><div class=\"messagebody\"><p><a href=\"https://ftalphaville.ft.com/marketslive/2018-03-26/\" target=\"_blank\">https://ftalphavil...tslive/2018-03-26/</a></p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">RA</span>\n\t\t\t\t\t\t\t\tmorning all\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">J L</span>\n\t\t\t\t\t\t\t\tMorning\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:10:50.000Z\" title=\"Wed Mar 28 2018 10:10:50 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:10:50 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:10 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522231865\" data-mid=\"1414001\" data-rawmessage=\"(@Arash: {thumbs_up} )\" id=\"webchat-msg-1414001\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:11am</span></span><div class=\"messagebody\"><p>(@Arash: <span class=\"webchat-emoticon webchat-emoticon--thumbs_up\" data-code=\"thumbs_up\">Thumbs up</span> )</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\t&apos;tis but a scratch on the FTSE100, still a down day for the index.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@BE am assured your that your Monday markets live was poured over incredibly carefully by people familiar with the matter\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\tShire up 17%\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Blank canvas</span>\n\t\t\t\t\t\t\t\tgood morning\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Typo</span>\n\t\t\t\t\t\t\t\tShire contributing 17 to the FTSE\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522231946\" data-mid=\"1414002\" data-rawmessage=\"So ..... Has the Panel bounced Takeda into a statement? It hasn&apos;t put in an approach yet, it&apos;s only thinking about it.\" id=\"webchat-msg-1414002\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:12am</span></span><div class=\"messagebody\"><p>So ..... Has the Panel bounced Takeda into a statement? It hasn&apos;t put in an approach yet, it&apos;s only thinking about it.</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522231952\" data-mid=\"1414003\" data-rawmessage=\"https://www.investegate.co.uk/takeda-pharm-co-ltd/rns/statement-regarding-shire/201803281023142333J/\" id=\"webchat-msg-1414003\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:12am</span></span><div class=\"messagebody\"><p><a href=\"https://www.investegate.co.uk/takeda-pharm-co-ltd/rns/statement-regarding-shire/201803281023142333J/\" target=\"_blank\">https://www.invest...1803281023142333J/</a></p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:12:28.000Z\" title=\"Wed Mar 28 2018 10:12:28 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:12:28 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:12 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522231963\" data-mid=\"1414004\" data-rawmessage=\"Takeda&apos;s consideration of such an offer is at a preliminary and exploratory stage and no approach has been made to the Board of Shire. There can be no certainty that an approach, if made, will lead to any transaction.\" id=\"webchat-msg-1414004\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:12am</span></span><div class=\"messagebody\"><blockquote><p>Takeda&apos;s consideration of such an offer is at a preliminary and exploratory stage and no approach has been made to the Board of Shire. There can be no certainty that an approach, if made, will lead to any transaction.</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Flaneur</span>\n\t\t\t\t\t\t\t\t:)\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\tShire is only 1.75% of FTSE100 weight\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">VV75</span>\n\t\t\t\t\t\t\t\tI&apos;m positive it was the panel\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522231987\" data-mid=\"1414005\" data-rawmessage=\"It does, however, offer a bunch of bullet points on why this makes sense.\" id=\"webchat-msg-1414005\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:13am</span></span><div class=\"messagebody\"><p>It does, however, offer a bunch of bullet points on why this makes sense.</p>\n</div></div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522231995\" data-mid=\"1414006\" data-rawmessage=\"&#xB7;     strengthen Takeda&apos;s core therapeutic areas of oncology, GI and neuroscience\n\n&#xB7;     accelerate Takeda&apos;s vision to be a leader in specialized medicines that are transformative to patients through the addition of Shire&apos;s leading global rare disease franchise\n\n&#xB7;     further enhance Takeda&apos;s robust R&amp;D strategy, concentrating on key therapeutic areas\n\n&#xB7;     reinforce a strong and large-molecule focused late-stage pipeline within Takeda&apos;s core therapeutic areas to complement Takeda&apos;s own pipeline and discovery capabilities\n\n&#xB7;     balance Takeda&apos;s geographic focus to align with the market opportunity in the U.S.\n\n&#xB7;     drive financial value from a strong combined financial profile\" id=\"webchat-msg-1414006\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:13am</span></span><div class=\"messagebody\"><blockquote><p>&#xB7;     strengthen Takeda&apos;s core therapeutic areas of oncology, GI and neuroscience</p>\n<p>&#xB7;     accelerate Takeda&apos;s vision to be a leader in specialized medicines that are transformative to patients through the addition of Shire&apos;s leading global rare disease franchise</p>\n<p>&#xB7;     further enhance Takeda&apos;s robust R&amp;D strategy, concentrating on key therapeutic areas</p>\n<p>&#xB7;     reinforce a strong and large-molecule focused late-stage pipeline within Takeda&apos;s core therapeutic areas to complement Takeda&apos;s own pipeline and discovery capabilities</p>\n<p>&#xB7;     balance Takeda&apos;s geographic focus to align with the market opportunity in the U.S.</p>\n<p>&#xB7;     drive financial value from a strong combined financial profile</p></blockquote>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:13:58.000Z\" title=\"Wed Mar 28 2018 10:13:58 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:13:58 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:13 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522232053\" data-mid=\"1414007\" data-rawmessage=\".... because this&apos;d be /gigantic/ for Takeda. I don&apos;t think anyone&apos;s talked in the past about it going .... what, $60bn EV?\" id=\"webchat-msg-1414007\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:14am</span></span><div class=\"messagebody\"><p>.... because this&apos;d be <em>gigantic</em> for Takeda. I don&apos;t think anyone&apos;s talked in the past about it going .... what, $60bn EV?</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">LJ</span>\n\t\t\t\t\t\t\t\tmorning\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Otter</span>\n\t\t\t\t\t\t\t\tHello friendos\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Philruffin</span>\n\t\t\t\t\t\t\t\tany news on zurn?\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232119\" data-mid=\"1414008\" data-rawmessage=\"The question follows is whether this bounces another party into moving. We talked a lot about Pfizer last year, of course, and also the possibility of Abbvie rekindling its interest.\" id=\"webchat-msg-1414008\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:15am</span></span><div class=\"messagebody\"><p>The question follows is whether this bounces another party into moving. We talked a lot about Pfizer last year, of course, and also the possibility of Abbvie rekindling its interest.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@BE i can confirm Panel bounced Takeda\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\tTakeda making hay whilst the QE sun shines and interest rates still low?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\twell done @BE for outing them\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232181\" data-mid=\"1414009\" data-rawmessage=\"There&apos;s an obvious forex angle here too. Shire was, going into today, about 50% cheaper in dollar terms than when Abbvie was trying to buy it. Picture pretty similar in yen.\" id=\"webchat-msg-1414009\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:16am</span></span><div class=\"messagebody\"><p>There&apos;s an obvious forex angle here too. Shire was, going into today, about 50% cheaper in dollar terms than when Abbvie was trying to buy it. Picture pretty similar in yen.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Typo</span>\n\t\t\t\t\t\t\t\tWell, 20% of 1.75% is...?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\tso minimum price &#xA3;45?\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:17:10.000Z\" title=\"Wed Mar 28 2018 10:17:10 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:17:10 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:17 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522232245\" data-mid=\"1414010\" data-rawmessage=\"Anyway, clearly this is breaking too late for us to have any real analysis. What we can do is chuck up some historic stuff saying Shire&apos;s undervalued assuming it&apos;s not going to breach banking covenants.\" id=\"webchat-msg-1414010\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:17am</span></span><div class=\"messagebody\"><p>Anyway, clearly this is breaking too late for us to have any real analysis. What we can do is chuck up some historic stuff saying Shire&apos;s undervalued assuming it&apos;s not going to breach banking covenants.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pharma</span>\n\t\t\t\t\t\t\t\tHasn&apos;t the tax position changed for US companies making overseas takeovers? Tax arbitrage seemed to be the primary motivation at the time.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">MnM</span>\n\t\t\t\t\t\t\t\tThe might just get me above water on Shire\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Lemmy</span>\n\t\t\t\t\t\t\t\t...but the tax inversion attraction has waned, cf Pfizer/Allergan\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232294\" data-mid=\"1414011\" data-rawmessage=\"Which relies largely on its haemophilia revenue not disappearing, which we can talk about a bit later.\" id=\"webchat-msg-1414011\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:18am</span></span><div class=\"messagebody\"><p>Which relies largely on its haemophilia revenue not disappearing, which we can talk about a bit later.</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232318\" data-mid=\"1414012\" data-rawmessage=\"Here&apos;s SocGen from a couple of weeks ago.\" id=\"webchat-msg-1414012\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:18am</span></span><div class=\"messagebody\"><p>Here&apos;s SocGen from a couple of weeks ago.</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:18:56.000Z\" title=\"Wed Mar 28 2018 10:18:56 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:18:56 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:18 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522232351\" data-mid=\"1414013\" data-rawmessage=\"Downgrades to forecasts have been exacerbated by de-rating.\nIn our view this can be restored by the following: 1) rising confidence in the sustainability of the haemophilia and HAE (severe facial swelling) franchises, 2) an exit from its cash-generative neuroscience unit, and/or 3) on upside surprises from Xiidra (eye care). We know Roche&#x2019;s Hemilibra is still a bugbear. But the independent haemophilia expert we consulted does not believe this drug will be disruptive because this market is very &#x201C;sticky&#x201D;. Hence, we see Shire&#x2019;s guidance of a 30% reduction in its non-inhibitor sales by 2020 as too cautious. Indeed, we think Sanofi would agree, having recently paid 20x 2018e P/E for Bioverativ, a pure haemophilia play. In 2H18 we expect the HAE focus will shift to SHP643&#x2019;s greater convenience and a rising tide of treatment rates. A sale of neuroscience (ADHD) would also be a catalyst as it would turbo-boost deleveraging. But in our view, a simple spin-off would also be good as it removes the negative EPS growth from the Vyvanse patent expiry. We think ex-ADHD it can repay all its debt as other franchises are highly sustainable.\" id=\"webchat-msg-1414013\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:19am</span></span><div class=\"messagebody\"><blockquote><p>Downgrades to forecasts have been exacerbated by de-rating.<br>\nIn our view this can be restored by the following: 1) rising confidence in the sustainability of the haemophilia and HAE (severe facial swelling) franchises, 2) an exit from its cash-generative neuroscience unit, and/or 3) on upside surprises from Xiidra (eye care). We know Roche&#x2019;s Hemilibra is still a bugbear. But the independent haemophilia expert we consulted does not believe this drug will be disruptive because this market is very &#x201C;sticky&#x201D;. Hence, we see Shire&#x2019;s guidance of a 30% reduction in its non-inhibitor sales by 2020 as too cautious. Indeed, we think Sanofi would agree, having recently paid 20x 2018e P/E for Bioverativ, a pure haemophilia play. In 2H18 we expect the HAE focus will shift to SHP643&#x2019;s greater convenience and a rising tide of treatment rates. A sale of neuroscience (ADHD) would also be a catalyst as it would turbo-boost deleveraging. But in our view, a simple spin-off would also be good as it removes the negative EPS growth from the Vyvanse patent expiry. We think ex-ADHD it can repay all its debt as other franchises are highly sustainable.</p></blockquote>\n</div></div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522232382\" data-mid=\"1414014\" data-rawmessage=\"Shire is poorly valued on consensus estimates due to concerns that its haemophilia and HAE franchises are not sustainable and that it cannot service its debts without ADHD. We strongly disagree. Our TP of &#xA3;75 is an average of 2018-20e EV/EBITA multiples (&#xA3;64) and DCF (&#xA3;86). Applying the 20x P/E Sanofi paid for Bioverativ would value Shire&#x2019;s haemophilia business at &#xA3;20/share. We continue to value ADHD at &#xA3;10/share. Subtracting this &#xA3;30 from the current share price implies that the remaining franchises (which account for nearly 50% of group EPS and are all durable, in our view) trade on a low-single-digit 2018e P/E &#x2013; hardly rational.\" id=\"webchat-msg-1414014\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:19am</span></span><div class=\"messagebody\"><blockquote><p>Shire is poorly valued on consensus estimates due to concerns that its haemophilia and HAE franchises are not sustainable and that it cannot service its debts without ADHD. We strongly disagree. Our TP of &#xA3;75 is an average of 2018-20e EV/EBITA multiples (&#xA3;64) and DCF (&#xA3;86). Applying the 20x P/E Sanofi paid for Bioverativ would value Shire&#x2019;s haemophilia business at &#xA3;20/share. We continue to value ADHD at &#xA3;10/share. Subtracting this &#xA3;30 from the current share price implies that the remaining franchises (which account for nearly 50% of group EPS and are all durable, in our view) trade on a low-single-digit 2018e P/E &#x2013; hardly rational.</p></blockquote>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232457\" data-mid=\"1414015\" data-rawmessage=\"(@Pharma: true. Shire&apos;s changed too. It&apos;s now a value play on haemo protection and a pipeline of potentials, like SHP643 and SHP647, rather than a tax avoidance mechanism.)\" id=\"webchat-msg-1414015\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:20am</span></span><div class=\"messagebody\"><p>(@Pharma: true. Shire&apos;s changed too. It&apos;s now a value play on haemo protection and a pipeline of potentials, like SHP643 and SHP647, rather than a tax avoidance mechanism.)</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Romeike</span>\n\t\t\t\t\t\t\t\tMinimum price &#xA3;52\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:22:06.000Z\" title=\"Wed Mar 28 2018 10:22:06 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:22:06 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:22 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522232541\" data-mid=\"1414016\" data-rawmessage=\"Interesting that you&apos;re struggling to find any analyst who&apos;s negative on Shire. Zero sells according to my data.\" id=\"webchat-msg-1414016\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:22am</span></span><div class=\"messagebody\"><p>Interesting that you&apos;re struggling to find any analyst who&apos;s negative on Shire. Zero sells according to my data.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\tMnM - from your keyboard to Takeda&apos;s ears...\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232578\" data-mid=\"1414017\" data-rawmessage=\"Citi&apos;s highly rated pharma team also buyers.\" id=\"webchat-msg-1414017\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:22am</span></span><div class=\"messagebody\"><p>Citi&apos;s highly rated pharma team also buyers.</p>\n</div></div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522232609\" data-mid=\"1414018\" data-rawmessage=\"Our forecasts encompass a robust growth outlook for Immunology (20% of FY17 sales) and new product launches, hemophillia (25% of sales) headwinds, and risks around further Fosrenol/Lialda/Pentasa generics (6% of sales). We also see pipeline potential that the market seems to ignore. This drives a 2018-23e sales/EBIT/EPS CAGR of 5/7/16%, DCF of valuation of &#xA3;56 (WACC 7.5%, g=0%) and bull-bear spread of &#xA3;75-31. We believe our forecasts represent a floor for earnings (Citi -3-6% below pre-Q4 consensus for 2018/19, 2-29% ahead in 2020-22e). Net debt stands at $19bn; despite a pay down schedule exceeding $10bn by 2022 we forecast excess cash flow of $1-6bn per annum, which we channel into buybacks starting 2019. We concede a lack of near term catalysts, over and above the Q1 acceptance of the SHP643 (HAE) filing, but with sentiment at all-time lows we struggle to see significant downside.\" id=\"webchat-msg-1414018\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:23am</span></span><div class=\"messagebody\"><blockquote><p>Our forecasts encompass a robust growth outlook for Immunology (20% of FY17 sales) and new product launches, hemophillia (25% of sales) headwinds, and risks around further Fosrenol/Lialda/Pentasa generics (6% of sales). We also see pipeline potential that the market seems to ignore. This drives a 2018-23e sales/EBIT/EPS CAGR of 5/7/16%, DCF of valuation of &#xA3;56 (WACC 7.5%, g=0%) and bull-bear spread of &#xA3;75-31. We believe our forecasts represent a floor for earnings (Citi -3-6% below pre-Q4 consensus for 2018/19, 2-29% ahead in 2020-22e). Net debt stands at $19bn; despite a pay down schedule exceeding $10bn by 2022 we forecast excess cash flow of $1-6bn per annum, which we channel into buybacks starting 2019. We concede a lack of near term catalysts, over and above the Q1 acceptance of the SHP643 (HAE) filing, but with sentiment at all-time lows we struggle to see significant downside.</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">MnM</span>\n\t\t\t\t\t\t\t\tLets hope, am now holding out for &#xA3;60+\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">rotorhead</span>\n\t\t\t\t\t\t\t\tOther news overnight from Roche&apos;s competitor drug could make you question whether the haemo franchise really is as vulnerable to Roche competition as previously thought. Questions over safety for Roche not going away.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Romeike</span>\n\t\t\t\t\t\t\t\tShire could easily retrace to &#xA3;50+ on it&apos;s own so a successful deal will need to offer a premium to fair value not just the current share price\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:23:37.000Z\" title=\"Wed Mar 28 2018 10:23:37 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:23:37 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:23 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522232632\" data-mid=\"1414019\" data-rawmessage=\"Target &#xA3;55. And .... well, there&apos;s a catalyst now!\" id=\"webchat-msg-1414019\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:23am</span></span><div class=\"messagebody\"><p>Target &#xA3;55. And .... well, there&apos;s a catalyst now!</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Romeike</span>\n\t\t\t\t\t\t\t\tFair value is around &#xA3;58 in my view\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232681\" data-mid=\"1414020\" data-rawmessage=\"Oh, incidentally, it&apos;s quite important to stress that Takeda hasn&apos;t contacted Shire yet.\" id=\"webchat-msg-1414020\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:24am</span></span><div class=\"messagebody\"><p>Oh, incidentally, it&apos;s quite important to stress that Takeda hasn&apos;t contacted Shire yet.</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232714\" data-mid=\"1414021\" data-rawmessage=\"Because Thomas Dittrich, Shire&apos;s CFO, bought &#xA3;303k of shares on the 15th March.\" id=\"webchat-msg-1414021\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:25am</span></span><div class=\"messagebody\"><p>Because Thomas Dittrich, Shire&apos;s CFO, bought &#xA3;303k of shares on the 15th March.</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:25:10.000Z\" title=\"Wed Mar 28 2018 10:25:10 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:25:10 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:25 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522232725\" data-mid=\"1414022\" data-rawmessage=\"Paid &#xA3;32.29.\" id=\"webchat-msg-1414022\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:25am</span></span><div class=\"messagebody\"><p>Paid &#xA3;32.29.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pharma</span>\n\t\t\t\t\t\t\t\t@BE, interesting, thanks. Pfizer presumably a bit less likely now they&apos;ve failed to off-load their consumer health unit.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Romeike</span>\n\t\t\t\t\t\t\t\tPfizer has the clout to make almost whatever acquisition they want at any time\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232794\" data-mid=\"1414023\" data-rawmessage=\"Anyway, the other rather less important thing re Shire today is Roche .......\" id=\"webchat-msg-1414023\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:26am</span></span><div class=\"messagebody\"><p>Anyway, the other rather less important thing re Shire today is Roche .......</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232829\" data-mid=\"1414024\" data-rawmessage=\"The Hemophilia Federation of America said overnight that five people have died while using Hemlibra\" id=\"webchat-msg-1414024\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:27am</span></span><div class=\"messagebody\"><p>The Hemophilia Federation of America said overnight that five people have died while using Hemlibra</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pharma</span>\n\t\t\t\t\t\t\t\t@Romeike, true. Plus they are deal-addicts.\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:27:21.000Z\" title=\"Wed Mar 28 2018 10:27:21 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:27:21 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:27 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522232856\" data-mid=\"1414025\" data-rawmessage=\"(Or emicizumab-kxwh, to give it its non-trade name, which we should do as a matter of course with drugs.)\" id=\"webchat-msg-1414025\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:27am</span></span><div class=\"messagebody\"><p>(Or emicizumab-kxwh, to give it its non-trade name, which we should do as a matter of course with drugs.)</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232919\" data-mid=\"1414026\" data-rawmessage=\"We knew one person had died on the HAVEN-1 trial, and there had been other reports in the public domain about possibly unrelated deaths, so it&apos;s very hard to read this.\" id=\"webchat-msg-1414026\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:28am</span></span><div class=\"messagebody\"><p>We knew one person had died on the HAVEN-1 trial, and there had been other reports in the public domain about possibly unrelated deaths, so it&apos;s very hard to read this.</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522232941\" data-mid=\"1414027\" data-rawmessage=\"We don&apos;t have any detail whatsoever on precise cause of death\" id=\"webchat-msg-1414027\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:29am</span></span><div class=\"messagebody\"><p>We don&apos;t have any detail whatsoever on precise cause of death</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:29:32.000Z\" title=\"Wed Mar 28 2018 10:29:32 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:29:32 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:29 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522232987\" data-mid=\"1414028\" data-rawmessage=\"Also, note that Hemlibra&apos;s only approved for the inhibitor population. It&apos;s non-inhibitor that&apos;s the much bigger market.\" id=\"webchat-msg-1414028\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:29am</span></span><div class=\"messagebody\"><p>Also, note that Hemlibra&apos;s only approved for the inhibitor population. It&apos;s non-inhibitor that&apos;s the much bigger market.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\t@pharma - in todays yield hungry world, Pfizer should have lots of strategic options to monetise their consumer helath unit\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233008\" data-mid=\"1414029\" data-rawmessage=\"Quick bit from Goldman.\" id=\"webchat-msg-1414029\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:30am</span></span><div class=\"messagebody\"><p>Quick bit from Goldman.</p>\n</div></div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522233024\" data-mid=\"1414030\" data-rawmessage=\"[W]e believe that the safety concerns on Hemlibra will\ndominate the discussion and we expect a more moderate penetration for Roche&#x2019;s Hemlibra here given that patients are well controlled on factor VIII replacements (Shire is the market leader here\" id=\"webchat-msg-1414030\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:30am</span></span><div class=\"messagebody\"><blockquote><p>[W]e believe that the safety concerns on Hemlibra will<br>\ndominate the discussion and we expect a more moderate penetration for Roche&#x2019;s Hemlibra here given that patients are well controlled on factor VIII replacements (Shire is the market leader here</p></blockquote>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:30:23.000Z\" title=\"Wed Mar 28 2018 10:30:23 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:30:23 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:30 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522233038\" data-mid=\"1414031\" data-rawmessage=\"Note that Shire&#x2019;s inhibitor/non-inhibitor products contributed to 5%/20% of Group sales in 2017, with concerns on the longer-term trajectory of this franchise being a key overhang on the stock. As we highlighted previously, we believe that Shire&#x2019;s current share price has little contribution being priced in for its Hemophilia franchise. For Roche, contribution from Hemlibra is more moderate with 2023E sales of CHF1.35bn (GSe) or c.2% of Group sales.\" id=\"webchat-msg-1414031\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:30am</span></span><div class=\"messagebody\"><blockquote><p>Note that Shire&#x2019;s inhibitor/non-inhibitor products contributed to 5%/20% of Group sales in 2017, with concerns on the longer-term trajectory of this franchise being a key overhang on the stock. As we highlighted previously, we believe that Shire&#x2019;s current share price has little contribution being priced in for its Hemophilia franchise. For Roche, contribution from Hemlibra is more moderate with 2023E sales of CHF1.35bn (GSe) or c.2% of Group sales.</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Romeike</span>\n\t\t\t\t\t\t\t\tThe thing is these companies are currently cash rich and have access to ultra cheap borrowing they can lock in for 10 years + - so now is the time to make strategic aquisitions\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\thow on earth do you pronounce emicizumab-kxwh?\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233059\" data-mid=\"1414032\" data-rawmessage=\"They&apos;re on a &#xA3;46 target, based on 11x 2019E EPS.\" id=\"webchat-msg-1414032\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:30am</span></span><div class=\"messagebody\"><p>They&apos;re on a &#xA3;46 target, based on 11x 2019E EPS.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">VV75</span>\n\t\t\t\t\t\t\t\thow would Takeda finance a 40+ bid??\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pharma</span>\n\t\t\t\t\t\t\t\t@BE, asking on the basis that you are omniscient; what does the kxwh stand for? Google has not helped.\n\t\t\t\t\t\t\t</div><div class=\"msg separator has-headshot\" data-timestamp=\"1522233134\" data-mid=\"1414033\" data-rawmessage=\"11:31AM\" id=\"webchat-msg-1414033\">\n\t<div class=\"messagebody\"><time class=\"o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:32:14.000Z\" title=\"Wed Mar 28 2018 10:32:14 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:32:14 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\tundefined\n\t\t\t\t\t\t\t\t</time></div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pharma</span>\n\t\t\t\t\t\t\t\t@GBKrona that&apos;s partly the point. When it&apos;s out of patent GPs will continue to write Heblibra on prescriptions.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@BE a bit of intrigue on the M&amp;A advisers here\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pharma</span>\n\t\t\t\t\t\t\t\t*Hemlibra*\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:33:48.000Z\" title=\"Wed Mar 28 2018 10:33:48 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:33:48 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:33 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522233243\" data-mid=\"1414034\" data-rawmessage=\"(@Pharma: kicks-wih. Kind of a breezy whistle at the end.)\" id=\"webchat-msg-1414034\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:34am</span></span><div class=\"messagebody\"><p>(@Pharma: kicks-wih. Kind of a breezy whistle at the end.)</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@BE specifically, one Francois Maisonrouge at Evercore and JPMorgan&apos;s Michele Colocci\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">tadam</span>\n\t\t\t\t\t\t\t\t@VV75 Yes, it will play out like Axalta did. People are dreaming of &#xA3;50+ with a bidder that can&apos;t afford it and hoping for Pfizer to save the day.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pharma</span>\n\t\t\t\t\t\t\t\t@BE :-)\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">MnM</span>\n\t\t\t\t\t\t\t\tMy previous ability to predict M&amp;A outcomes, meant I sold Fidessa the day before the deal broke......\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233321\" data-mid=\"1414035\" data-rawmessage=\"Okay, we&apos;ll come back to Shire before the end -- and Arash, currently slumming it among the ROTR, will hopefully continue to provide far more insight than I can offer over here.\" id=\"webchat-msg-1414035\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:35am</span></span><div class=\"messagebody\"><p>Okay, we&apos;ll come back to Shire before the end -- and Arash, currently slumming it among the ROTR, will hopefully continue to provide far more insight than I can offer over here.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@BE From a 2016 story i wrote on Shire/Baxalta - &quot;Working with advisers Francois Maisonrouge from Evercore and Michele Colocci from Morgan Stanley, Shire revised the terms of its offer at least three times over the months.&quot; https://www.ft.com/content/d4bb320a-b86b-11e5-b151-8e15c9a029fb\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Lemmy</span>\n\t\t\t\t\t\t\t\tArash: they worked on Shire&apos;s defence from Abbvie too\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233375\" data-mid=\"1414036\" data-rawmessage=\"Over here, I guess we should mention a couple of other stocks.\" id=\"webchat-msg-1414036\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:36am</span></span><div class=\"messagebody\"><p>Over here, I guess we should mention a couple of other stocks.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">nichoman</span>\n\t\t\t\t\t\t\t\t@MnM I sold ARM the day before the Softbank deal !\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@Lammy Yep! Shire chairman used to run Credit Suisse M&amp;A and her top pharma banker was Francois Maisonrouge...(some top bankers in M&amp;A circles, like to call him Frankie Red House)\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">nichoman</span>\n\t\t\t\t\t\t\t\tanything on Providence -- finally does a deal\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:37:01.000Z\" title=\"Wed Mar 28 2018 10:37:01 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:37:01 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:37 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522233436\" data-mid=\"1414037\" data-rawmessage=\"Utilities very, very strong.\" id=\"webchat-msg-1414037\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:37am</span></span><div class=\"messagebody\"><p>Utilities very, very strong.</p>\n</div></div><div class=\"msg price has-headshot\" data-timestamp=\"1522233442\" data-mid=\"1414038\" data-rawmessage=\"&lt;strong&gt;United Utilities Group PLC (UU.:LSE):&lt;/strong&gt; Last: 703.20, up 34.8 (+5.21%), High: 703.20, Low: 668.00, Volume: 1.53m\" id=\"webchat-msg-1414038\">\n\t<div class=\"messagebody\"><strong>United Utilities Group PLC (UU.:LSE):</strong> Last: 703.20, up 34.8 (+5.21%), High: 703.20, Low: 668.00, Volume: 1.53m</div></div><div class=\"msg price has-headshot\" data-timestamp=\"1522233453\" data-mid=\"1414039\" data-rawmessage=\"&lt;strong&gt;National Grid PLC (NG.:LSE):&lt;/strong&gt; Last: 784.90, up 21.4 (+2.80%), High: 785.30, Low: 763.40, Volume: 2.92m\" id=\"webchat-msg-1414039\">\n\t<div class=\"messagebody\"><strong>National Grid PLC (NG.:LSE):</strong> Last: 784.90, up 21.4 (+2.80%), High: 785.30, Low: 763.40, Volume: 2.92m</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:37:28.000Z\" title=\"Wed Mar 28 2018 10:37:28 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:37:28 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:37 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg price has-headshot\" data-timestamp=\"1522233463\" data-mid=\"1414040\" data-rawmessage=\"&lt;strong&gt;Severn Trent PLC (SVT:LSE):&lt;/strong&gt; Last: 1,793, up 51 (+2.93%), High: 1,793, Low: 1,733, Volume: 382.76k\" id=\"webchat-msg-1414040\">\n\t<div class=\"messagebody\"><strong>Severn Trent PLC (SVT:LSE):</strong> Last: 1,793, up 51 (+2.93%), High: 1,793, Low: 1,733, Volume: 382.76k</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Electric Dragon</span>\n\t\t\t\t\t\t\t\t@GBKrona, I guess &quot;eeMICKeezyoomab-[noise that sounds like a sneeze]&quot;\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233534\" data-mid=\"1414041\" data-rawmessage=\"There&apos;s a bunch of interesting stuff around on the sector, chief of which is probably Exane talking M&amp;A.\" id=\"webchat-msg-1414041\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:38am</span></span><div class=\"messagebody\"><p>There&apos;s a bunch of interesting stuff around on the sector, chief of which is probably Exane talking M&amp;A.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@BE That&apos;s it for me. Lots more to come in our full story going up on Shire shortly.  Would note that Shire only recently managed to get a new CFO up and running. https://globenewswire.com/news-release/2017/11/20/1197451/0/en/Shire-plc-Directorate-change.html\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@BE some talk of rotation out of Techs into Utilities at least in the states ....\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233574\" data-mid=\"1414042\" data-rawmessage=\"Earnings season has proven the sector&apos;s decelerating and will stagnate in 2020&#x2013;21.\" id=\"webchat-msg-1414042\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:39am</span></span><div class=\"messagebody\"><p>Earnings season has proven the sector&apos;s decelerating and will stagnate in 2020&#x2013;21.</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:39:34.000Z\" title=\"Wed Mar 28 2018 10:39:34 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:39:34 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:39 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522233589\" data-mid=\"1414043\" data-rawmessage=\"(@Arash: {thumbs_up} You&apos;re welcome back any time.)\" id=\"webchat-msg-1414043\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:39am</span></span><div class=\"messagebody\"><p>(@Arash: <span class=\"webchat-emoticon webchat-emoticon--thumbs_up\" data-code=\"thumbs_up\">Thumbs up</span> You&apos;re welcome back any time.)</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233616\" data-mid=\"1414044\" data-rawmessage=\"So ........... can M&amp;A fix it?\" id=\"webchat-msg-1414044\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:40am</span></span><div class=\"messagebody\"><p>So ........... can M&amp;A fix it?</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233623\" data-mid=\"1414045\" data-rawmessage=\"No.\" id=\"webchat-msg-1414045\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:40am</span></span><div class=\"messagebody\"><p>No.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\tIn other news, Retail Sales fall for first time since October\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Arash Massoudi, FT</span>\n\t\t\t\t\t\t\t\t@BE thanks. Ciao ROTR.\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:41:08.000Z\" title=\"Wed Mar 28 2018 10:41:08 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:41:08 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:41 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522233683\" data-mid=\"1414047\" data-rawmessage=\"M&amp;A is often seen as a solution, especially in late cycle conditions, although the industry is probably in the early stages of a new cycle. Yet we show how i) balance sheets don&#x2019;t allow for large all-cash (EPS-enhancing) deals; ii) going down the credit ladder provides little valuation upside (B-rated utilities historically trade on PE premia of just 7% to A-rated ones and that gap has narrowed in recent months); and iii) with network/service/renewable assets trading on ~2x BV for ~11% ROE, EPS uplift pre-Purchase Price Accounting must be greater than 45% for a deal to accrete EPS.\" id=\"webchat-msg-1414047\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:41am</span></span><div class=\"messagebody\"><blockquote><p>M&amp;A is often seen as a solution, especially in late cycle conditions, although the industry is probably in the early stages of a new cycle. Yet we show how i) balance sheets don&#x2019;t allow for large all-cash (EPS-enhancing) deals; ii) going down the credit ladder provides little valuation upside (B-rated utilities historically trade on PE premia of just 7% to A-rated ones and that gap has narrowed in recent months); and iii) with network/service/renewable assets trading on ~2x BV for ~11% ROE, EPS uplift pre-Purchase Price Accounting must be greater than 45% for a deal to accrete EPS.</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@Miss Piggyyes cbi report can be hit or miss in relation to official sales but a surprise large fall never a good thing.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233709\" data-mid=\"1414048\" data-rawmessage=\"So expect more portfolio restructuring / asset swaps rather than takeovers, says Exane.\" id=\"webchat-msg-1414048\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:41am</span></span><div class=\"messagebody\"><p>So expect more portfolio restructuring / asset swaps rather than takeovers, says Exane.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tsterling however has taken it reasonably well\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233766\" data-mid=\"1414049\" data-rawmessage=\"So buy those. Buy the breakup candidates, not the takeover targets.\" id=\"webchat-msg-1414049\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:42am</span></span><div class=\"messagebody\"><p>So buy those. Buy the breakup candidates, not the takeover targets.</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:43:04.000Z\" title=\"Wed Mar 28 2018 10:43:04 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:43:04 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:43 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522233799\" data-mid=\"1414050\" data-rawmessage=\"The historical correlation between share price performance and two-year forward EPS CAGR is high at greater than 60%, whereas there is no real evidence of equity value uplift from growing company size (market cap to tangible fixed asset ratios have been stagnant or declining). Therefore announced deals should be judged on the potential earnings growth they generate rather than on &#x2018;strategic&#x2019; positioning reasons as the former is a better indicator of share price performance.\" id=\"webchat-msg-1414050\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:43am</span></span><div class=\"messagebody\"><blockquote><p>The historical correlation between share price performance and two-year forward EPS CAGR is high at greater than 60%, whereas there is no real evidence of equity value uplift from growing company size (market cap to tangible fixed asset ratios have been stagnant or declining). Therefore announced deals should be judged on the potential earnings growth they generate rather than on &#x2018;strategic&#x2019; positioning reasons as the former is a better indicator of share price performance.</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tanything on ge? both companies silent\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\t@red: also, later, US GDP QoQ (Q4) 13:30\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233836\" data-mid=\"1414051\" data-rawmessage=\"They&apos;re pro Endessa, Enel, Engie, Iberdrola, National Grid, SSE and Veolia.\" id=\"webchat-msg-1414051\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:43am</span></span><div class=\"messagebody\"><p>They&apos;re pro Endessa, Enel, Engie, Iberdrola, National Grid, SSE and Veolia.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@Miss Piggyits a last look so will likely be discounted imo\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\t@red: ah its a revision. apols.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233918\" data-mid=\"1414052\" data-rawmessage=\"Anyhoo ....... util sector&apos;s up for dull reasons like rotation into bond proxies but I thought that was an interesting wee diversion.\" id=\"webchat-msg-1414052\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:45am</span></span><div class=\"messagebody\"><p>Anyhoo ....... util sector&apos;s up for dull reasons like rotation into bond proxies but I thought that was an interesting wee diversion.</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:45:10.000Z\" title=\"Wed Mar 28 2018 10:45:10 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:45:10 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:45 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg separator has-headshot\" data-timestamp=\"1522233925\" data-mid=\"1414053\" data-rawmessage=\"11:45AM\" id=\"webchat-msg-1414053\">\n\t<div class=\"messagebody\"><time class=\"o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:45:25.000Z\" title=\"Wed Mar 28 2018 10:45:25 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:45:25 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\tundefined\n\t\t\t\t\t\t\t\t</time></div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tGood late morning assorted miscellaneous people\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233964\" data-mid=\"1414054\" data-rawmessage=\"Nothing, sadly, on GE .....\" id=\"webchat-msg-1414054\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:46am</span></span><div class=\"messagebody\"><p>Nothing, sadly, on GE .....</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tWhat hit Microsoft yesterday?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\tre US GDP  but this time Q1 2018 the sharp drop off in forecast from Atlanta Fed now cast caught my eye https://www.frbatlanta.org/-/media/images/cqer/research/gdpnow/gdpnow-forecast-evolution.gif?h=421&amp;w=542&amp;la=en\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522233997\" data-mid=\"1414055\" data-rawmessage=\"..... which moved yesterday on the idea that Buffett might buy a stake.\" id=\"webchat-msg-1414055\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:46am</span></span><div class=\"messagebody\"><p>..... which moved yesterday on the idea that Buffett might buy a stake.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">J L</span>\n\t\t\t\t\t\t\t\t@Mouselet: I am not miscellaneous :-)\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:46:36.000Z\" title=\"Wed Mar 28 2018 10:46:36 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:46:36 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:46 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522234011\" data-mid=\"1414056\" data-rawmessage=\"(@Mouselet: didn&apos;t Merrill cut forecasts?)\" id=\"webchat-msg-1414056\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:46am</span></span><div class=\"messagebody\"><p>(@Mouselet: didn&apos;t Merrill cut forecasts?)</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tusdjpy performing remarkably well given risk aversion last 24 hours. given jap year end soon done, maybe tide turning here.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\t@Mouselet: read-across from FANG?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@FATDAZatlanta is often all over the place and q1 is known to be a soft quarter, so they always discount this. i know its daft but thats how they talk up the q1 numbers.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234077\" data-mid=\"1414057\" data-rawmessage=\"....... which is ........... plausible? I guess? But buying on speculation that another investor might be buying is some serious Six Degrees of Separation stuff.\" id=\"webchat-msg-1414057\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:47am</span></span><div class=\"messagebody\"><p>....... which is ........... plausible? I guess? But buying on speculation that another investor might be buying is some serious Six Degrees of Separation stuff.</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234088\" data-mid=\"1414058\" data-rawmessage=\"Nothing new either on Zurich Financial.\" id=\"webchat-msg-1414058\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:48am</span></span><div class=\"messagebody\"><p>Nothing new either on Zurich Financial.</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:48:27.000Z\" title=\"Wed Mar 28 2018 10:48:27 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:48:27 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:48 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522234122\" data-mid=\"1414059\" data-rawmessage=\".... Sorry, Zurich Insurance. Down 0.8% live.\" id=\"webchat-msg-1414059\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:48am</span></span><div class=\"messagebody\"><p>.... Sorry, Zurich Insurance. Down 0.8% live.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tbuffett will buy, its just a question of when. will be similar to BoA deal. but importantly it puts a floor in the stock (in the self fulfilling way)\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@red  I hadnt seen a deviation / change that large  before and have followed for last three  years or so  and of course US loves to game their numbers  so we shall see ......\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">urgeview</span>\n\t\t\t\t\t\t\t\twhat is the market cap of takeda ?\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234200\" data-mid=\"1414060\" data-rawmessage=\"On terms of what we do have ...... how about some retail?\" id=\"webchat-msg-1414060\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:50am</span></span><div class=\"messagebody\"><p>On terms of what we do have ...... how about some retail?</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tTesla.  How funted is Tesla?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@Mouseletbadly.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234251\" data-mid=\"1414061\" data-rawmessage=\"CBI for February shows first fall in five months, which is entirely unsurprising given it was snowing for a lot of February.\" id=\"webchat-msg-1414061\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:50am</span></span><div class=\"messagebody\"><p>CBI for February shows first fall in five months, which is entirely unsurprising given it was snowing for a lot of February.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@FATDAZtoday is q4 2017\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\tRe TSLA am alone in thinking that they could genuinely run out of money\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tI get the impression they have enormous debt from building a giant factory that doesn&apos;t actually factory, plus an extra enormous debt from buying a solar panel operation just as the bottom fell out of the solar subsidies\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Grouchmonkey</span>\n\t\t\t\t\t\t\t\tInteresting comment from John Authers. Now Tesla gone south a bit, everyone shorting it which is counter-intuitive\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@FATDAZno u are not, currently fighting it out for title of most shorted big cap stock\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\twhich sounds like a good way to run out of money to me\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:51:32.000Z\" title=\"Wed Mar 28 2018 10:51:32 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:51:32 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:51 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522234307\" data-mid=\"1414062\" data-rawmessage=\"Did I say February? March, obviously. Anyway, balance of -8 from +8 in the previous month, against a consensus of -- get this! -- +15\" id=\"webchat-msg-1414062\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:51am</span></span><div class=\"messagebody\"><p>Did I say February? March, obviously. Anyway, balance of -8 from +8 in the previous month, against a consensus of -- get this! -- +15</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\t@Grouchmonkey: momentum?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@Red well aware of that  thc  but I prefer to focus on what&apos;s happening now not upto 6 months before :)\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Grouchmonkey</span>\n\t\t\t\t\t\t\t\t@FATDAZ you are not alone. Been telling everyone who will listen since last September\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\ti always think its important for car companies to actually build cars and deliver them. maybe im wrong.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234371\" data-mid=\"1414063\" data-rawmessage=\"Anecdotal reports suggest pub trade, for instance, was down 20% during the Beast so I&apos;m not sure why the consensus didn&apos;t adjust downwards. Anyway, sector mostly unmoved.\" id=\"webchat-msg-1414063\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:52am</span></span><div class=\"messagebody\"><p>Anecdotal reports suggest pub trade, for instance, was down 20% during the Beast so I&apos;m not sure why the consensus didn&apos;t adjust downwards. Anyway, sector mostly unmoved.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\tre TSLA thx @Red @Grouchmonkey\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234391\" data-mid=\"1414064\" data-rawmessage=\"The exception is ABF\" id=\"webchat-msg-1414064\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:53am</span></span><div class=\"messagebody\"><p>The exception is ABF</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:53:01.000Z\" title=\"Wed Mar 28 2018 10:53:01 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:53:01 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:53 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg price has-headshot\" data-timestamp=\"1522234396\" data-mid=\"1414065\" data-rawmessage=\"&lt;strong&gt;Associated British Foods plc (ABF:LSE):&lt;/strong&gt; Last: 2,467, up 44 (+1.82%), High: 2,484, Low: 2,436, Volume: 464.13k\" id=\"webchat-msg-1414065\">\n\t<div class=\"messagebody\"><strong>Associated British Foods plc (ABF:LSE):</strong> Last: 2,467, up 44 (+1.82%), High: 2,484, Low: 2,436, Volume: 464.13k</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tI think if you have eight hundred million dollars of customer deposits it becomes a matter of some urgency to build and deliver the associated vehicles\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234415\" data-mid=\"1414066\" data-rawmessage=\"Which is getting a push from Geoff Ruddell at Morgan Stanley.\" id=\"webchat-msg-1414066\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:53am</span></span><div class=\"messagebody\"><p>Which is getting a push from Geoff Ruddell at Morgan Stanley.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tI will be a bit sad if this also kills SpaceX\n\t\t\t\t\t\t\t</div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522234438\" data-mid=\"1414067\" data-rawmessage=\".... In a sector full of companies struggling in the face of structural\npressures, we believe that Inditex and ABF/Primark stand out as high quality businesses that investors should generally want to own over the long term.\" id=\"webchat-msg-1414067\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:53am</span></span><div class=\"messagebody\"><blockquote><p>.... In a sector full of companies struggling in the face of structural<br>\npressures, we believe that Inditex and ABF/Primark stand out as high quality businesses that investors should generally want to own over the long term.</p></blockquote>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:54:03.000Z\" title=\"Wed Mar 28 2018 10:54:03 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:54:03 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:54 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522234458\" data-mid=\"1414068\" data-rawmessage=\"The main difference is that one&apos;s cheap and the other&apos;s expensive.\" id=\"webchat-msg-1414068\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:54am</span></span><div class=\"messagebody\"><p>The main difference is that one&apos;s cheap and the other&apos;s expensive.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@FATDAZwhat you can watch for is the revisions to q1. u can often start at near 2% and end up with a negative at the final revision.\n\t\t\t\t\t\t\t</div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522234471\" data-mid=\"1414069\" data-rawmessage=\"On our analysis, the current ABF share price implies Primark is currently being valued at less than 12x Cal 2019 earnings, versus 20x at Inditex. We see Primark as much less mature, so this seems anomalous to us.\" id=\"webchat-msg-1414069\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:54am</span></span><div class=\"messagebody\"><blockquote><p>On our analysis, the current ABF share price implies Primark is currently being valued at less than 12x Cal 2019 earnings, versus 20x at Inditex. We see Primark as much less mature, so this seems anomalous to us.</p></blockquote>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234475\" data-mid=\"1414070\" data-rawmessage=\"But also ........\" id=\"webchat-msg-1414070\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:54am</span></span><div class=\"messagebody\"><p>But also ........</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@mouselet @red lets see  but I am not bullish\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:54:34.000Z\" title=\"Wed Mar 28 2018 10:54:34 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:54:34 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:54 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522234489\" data-mid=\"1414071\" data-rawmessage=\"We conclude that it is ABF that represents the better buying opportunity for those with a c12-month investment horizon. We think profits at Primark are likely to inflect positively in that time frame, whereas we see no sign of the FX headwinds that are hampering Inditex abating.\" id=\"webchat-msg-1414071\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:54am</span></span><div class=\"messagebody\"><blockquote><p>We conclude that it is ABF that represents the better buying opportunity for those with a c12-month investment horizon. We think profits at Primark are likely to inflect positively in that time frame, whereas we see no sign of the FX headwinds that are hampering Inditex abating.</p></blockquote>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234511\" data-mid=\"1414072\" data-rawmessage=\"So Inditex goes from &#x20AC;30 to &#x20AC;26 and stays equal-weight,\" id=\"webchat-msg-1414072\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:55am</span></span><div class=\"messagebody\"><p>So Inditex goes from &#x20AC;30 to &#x20AC;26 and stays equal-weight,</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234528\" data-mid=\"1414073\" data-rawmessage=\"ABF stays &#xA3;30 and goes overweight.\" id=\"webchat-msg-1414073\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:55am</span></span><div class=\"messagebody\"><p>ABF stays &#xA3;30 and goes overweight.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@ mouselet those deposits are  the equivalent of 67 days of Tesla cash burn\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:55:26.000Z\" title=\"Wed Mar 28 2018 10:55:26 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:55:26 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:55 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg separator has-headshot\" data-timestamp=\"1522234541\" data-mid=\"1414074\" data-rawmessage=\"11:55AM\" id=\"webchat-msg-1414074\">\n\t<div class=\"messagebody\"><time class=\"o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:55:41.000Z\" title=\"Wed Mar 28 2018 10:55:41 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:55:41 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\tundefined\n\t\t\t\t\t\t\t\t</time></div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tcompared to any other quarter, it often gets benefit of doubt. well at least during last decade or so. but thats a lot to do with the btfd mentality the mkt has had.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Puntino</span>\n\t\t\t\t\t\t\t\tTesla  - and promsing to pay clients up to $ 800mln to buy back their cars.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tlightweights, viewing a blizzard as a reason not to go to the pub rather than a reason to stay in the pub indefinitely\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\ti think they have to have delivered 2500 cars when they report\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">kim</span>\n\t\t\t\t\t\t\t\tWhat I don&apos;t &quot;get&quot; is how you can burn so much cash so quickly when you aren&apos;t making anything.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234634\" data-mid=\"1414075\" data-rawmessage=\"Okay, the sellside on Shire-Takeda&apos;s beginning to drip through.\" id=\"webchat-msg-1414075\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:57am</span></span><div class=\"messagebody\"><p>Okay, the sellside on Shire-Takeda&apos;s beginning to drip through.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@TED TBH  would take a miracle to change my bearish $ view  but I am open to persuasion\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tper week\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234654\" data-mid=\"1414076\" data-rawmessage=\"Here&apos;s UBS.\" id=\"webchat-msg-1414076\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:57am</span></span><div class=\"messagebody\"><p>Here&apos;s UBS.</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:57:27.000Z\" title=\"Wed Mar 28 2018 10:57:27 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:57:27 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:57 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522234662\" data-mid=\"1414077\" data-rawmessage=\"Since Takeda&apos;s market cap is close to Shire&apos;s we assume a\npotential offer would have to include a substantial percentage in equity and how Shire&apos;s board and shareholders would react is hard to predict. However as Shire&apos;s share price is significantly below the NPV of our cash flow estimates, Takeda could trigger discussion of other bidders.\" id=\"webchat-msg-1414077\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:57am</span></span><div class=\"messagebody\"><blockquote><p>Since Takeda&apos;s market cap is close to Shire&apos;s we assume a<br>\npotential offer would have to include a substantial percentage in equity and how Shire&apos;s board and shareholders would react is hard to predict. However as Shire&apos;s share price is significantly below the NPV of our cash flow estimates, Takeda could trigger discussion of other bidders.</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@Kim well that gigafactory  probably eats up quite  a lot of cash :)\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234697\" data-mid=\"1414078\" data-rawmessage=\".... they were not expecting this, it appears.\" id=\"webchat-msg-1414078\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:58am</span></span><div class=\"messagebody\"><p>.... they were not expecting this, it appears.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tah, per week.  That is starting to be actually more deliveries than Jaguar.uk\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234704\" data-mid=\"1414079\" data-rawmessage=\"And were neutral.\" id=\"webchat-msg-1414079\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:58am</span></span><div class=\"messagebody\"><p>And were neutral.</p>\n</div></div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T10:58:22.000Z\" title=\"Wed Mar 28 2018 10:58:22 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 10:58:22 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t11:58 am\n\t\t\t\t\t\t\t\t</time><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522234717\" data-mid=\"1414080\" data-rawmessage=\"Shire does not strike us as an obvious take-over candidate. There is presumably a price at which the financial engineering would work. However, Shire&apos;s specialty focus and mix of therapeutic foci means that most buyers would struggle to extract substantial operational synergies while escaping from competition problems, in our view. Also Shire&apos;s low corporate tax rate could rise in most scenarios were the company acquired. It would also be a bold acquisition in our view given the uncertain trajectory of Shire&apos;s haemophilia business. A merger of equals in this context might be more feasible.\" id=\"webchat-msg-1414080\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:58am</span></span><div class=\"messagebody\"><blockquote><p>Shire does not strike us as an obvious take-over candidate. There is presumably a price at which the financial engineering would work. However, Shire&apos;s specialty focus and mix of therapeutic foci means that most buyers would struggle to extract substantial operational synergies while escaping from competition problems, in our view. Also Shire&apos;s low corporate tax rate could rise in most scenarios were the company acquired. It would also be a bold acquisition in our view given the uncertain trajectory of Shire&apos;s haemophilia business. A merger of equals in this context might be more feasible.</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Mouselet</span>\n\t\t\t\t\t\t\t\tkim: They&apos;re making factories; indeed they&apos;re paying very expensive German factory makers to make them factories\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\ti actually dont think there is the demand for those cheaper models. thats why they are stalling.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234760\" data-mid=\"1414081\" data-rawmessage=\"The argument UBS makes here is that, even if Takeda chooses to walk away, it&apos;ll have lit a fire under management&apos;s feet.\" id=\"webchat-msg-1414081\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">11:59am</span></span><div class=\"messagebody\"><p>The argument UBS makes here is that, even if Takeda chooses to walk away, it&apos;ll have lit a fire under management&apos;s feet.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">kim</span>\n\t\t\t\t\t\t\t\tPerhaps they should stick to making (collecting) factories?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tanyone can put up a grand for a deposit but when the final price can hits north of 50 grand with extras, its a diff matter considering that not all of these folks are going to be able to charge on their own terms.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Grouchmonkey</span>\n\t\t\t\t\t\t\t\t@red not that cheap though. Have you seen the price for the Model X?\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234852\" data-mid=\"1414082\" data-rawmessage=\"Shire derated because the market doesn&apos;t trust its capital allocation policies and, by extension, its board. Can that remain when there&apos;s an /identified/ predator circling?\" id=\"webchat-msg-1414082\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:00pm</span></span><div class=\"messagebody\"><p>Shire derated because the market doesn&apos;t trust its capital allocation policies and, by extension, its board. Can that remain when there&apos;s an <em>identified</em> predator circling?</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Grouchmonkey</span>\n\t\t\t\t\t\t\t\tAh you have\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:01:11.000Z\" title=\"Wed Mar 28 2018 11:01:11 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:01:11 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t12:01 pm\n\t\t\t\t\t\t\t\t</time><div class=\"msg separator has-headshot\" data-timestamp=\"1522234886\" data-mid=\"1414083\" data-rawmessage=\"12:01PM\" id=\"webchat-msg-1414083\">\n\t<div class=\"messagebody\"><time class=\"o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:01:26.000Z\" title=\"Wed Mar 28 2018 11:01:26 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:01:26 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\tundefined\n\t\t\t\t\t\t\t\t</time></div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\tre TSLA see this from Feb n backlogs  https://electrek.co/2018/02/21/tesla-delay-model-s-x-orders-demand-backlog/\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@Grouchmonkeyits the mass mkt car that has to take off, the 3. otherwise it cannot poss support its valuation\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234906\" data-mid=\"1414084\" data-rawmessage=\"Oh, hey, it&apos;s midday and it feels like we&apos;ve only mentioned one stock.\" id=\"webchat-msg-1414084\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:01pm</span></span><div class=\"messagebody\"><p>Oh, hey, it&apos;s midday and it feels like we&apos;ve only mentioned one stock.</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522234935\" data-mid=\"1414085\" data-rawmessage=\"ROTR have gone off about Tesla though, so I guess that adds variety.\" id=\"webchat-msg-1414085\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:02pm</span></span><div class=\"messagebody\"><p>ROTR have gone off about Tesla though, so I guess that adds variety.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\ttotal sales of x and s for 2018 likely to be less than 100000 cars\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Blank canvas</span>\n\t\t\t\t\t\t\t\tthanks for today.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Provender</span>\n\t\t\t\t\t\t\t\tAnd they&apos;re still rolling out superchargers of course, which is still  one of the best reasons to buy a Tesla over any other BEV\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\tthe success of Elon Musk is that  he has shamed all the other car companies into bringing forward their electric cars.\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:03:07.000Z\" title=\"Wed Mar 28 2018 11:03:07 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:03:07 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t12:03 pm\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522235002\" data-mid=\"1414087\" data-rawmessage=\"Just to catch up on the Musk news .... Moody&#x2019;s downgraded Tesla&apos;s high-yield yesterday\" id=\"webchat-msg-1414087\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:03pm</span></span><div class=\"messagebody\"><p>Just to catch up on the Musk news .... Moody&#x2019;s downgraded Tesla&apos;s high-yield yesterday</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522235026\" data-mid=\"1414088\" data-rawmessage=\"National Transportation Safety Board is investigating an accident on  Highway 101\" id=\"webchat-msg-1414088\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:03pm</span></span><div class=\"messagebody\"><p>National Transportation Safety Board is investigating an accident on  Highway 101</p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522235053\" data-mid=\"1414089\" data-rawmessage=\"And, perhaps most importantly, Nvidia has suspended its autonomous driving programme.\" id=\"webchat-msg-1414089\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:04pm</span></span><div class=\"messagebody\"><p>And, perhaps most importantly, Nvidia has suspended its autonomous driving programme.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Soundbuy</span>\n\t\t\t\t\t\t\t\tcheers all\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Otter</span>\n\t\t\t\t\t\t\t\tIf an electric car crashes into a river does it zap all of the fish?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pseudonym</span>\n\t\t\t\t\t\t\t\tI do hope autonomous car development hasn&apos;t hit a fleshy wall.\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:04:59.000Z\" title=\"Wed Mar 28 2018 11:04:59 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:04:59 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t12:04 pm\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522235114\" data-mid=\"1414090\" data-rawmessage=\"There&apos;s also Waymo purchasing 20K Jaguars, and the usual talk around with regards bottlenecks in Model 3 battery production, and and and ......\" id=\"webchat-msg-1414090\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:05pm</span></span><div class=\"messagebody\"><p>There&apos;s also Waymo purchasing 20K Jaguars, and the usual talk around with regards bottlenecks in Model 3 battery production, and and and ......</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@Miss Piggyit has cost many many billions though. and as of now its still largely coal that will be creating the electricity for these car batteries. thats before you start on the costs of battery creation and disposal.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522235134\" data-mid=\"1414091\" data-rawmessage=\"Oppenheimer says:\" id=\"webchat-msg-1414091\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:05pm</span></span><div class=\"messagebody\"><p>Oppenheimer says:</p>\n</div></div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522235147\" data-mid=\"1414092\" data-rawmessage=\"We continue to believe that pressure on TSLA&#x2019;s debt could be amplified in its equity pricing, especially given concerns around delays in reaching profitability. We also believe the increased scrutiny of ADAS programs by regulators along with the NTSB investigation could bring to light any technical issues in TSLA&#x2019;s system as well as question its implied technical leadership\" id=\"webchat-msg-1414092\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:05pm</span></span><div class=\"messagebody\"><blockquote><p>We continue to believe that pressure on TSLA&#x2019;s debt could be amplified in its equity pricing, especially given concerns around delays in reaching profitability. We also believe the increased scrutiny of ADAS programs by regulators along with the NTSB investigation could bring to light any technical issues in TSLA&#x2019;s system as well as question its implied technical leadership</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\t@red: re coal, so what, so long as kiddies lungs don&apos;t inhale ... wait we&apos;ve hyad this conversation in here before ...\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:05:53.000Z\" title=\"Wed Mar 28 2018 11:05:53 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:05:53 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t12:05 pm\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522235168\" data-mid=\"1414093\" data-rawmessage=\"And Morgan Stanley says:\" id=\"webchat-msg-1414093\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:06pm</span></span><div class=\"messagebody\"><p>And Morgan Stanley says:</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@here how many other RTA  fatalities through driver error  were there in the US  on the day of the  driverless vehicle I wonder\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pseudonym</span>\n\t\t\t\t\t\t\t\t@red In the UK it&apos;s Gas and Nuclear before coal.\n\t\t\t\t\t\t\t</div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522235207\" data-mid=\"1414094\" data-rawmessage=\"We&apos;d use further weakness from here as an opportunity to build an Equal-weight position in the stock. Tesla is trading at the midpoint between our base case and bear case valuation. We see Tesla as modestly undervalued with very high risk, particularly for investors who are not comfortable with extreme volatility. We continue to expect that Model 3 production bottlenecks will be mitigated, but we do not expect a 5k/week run-rate before deep into the final quarter of 2018. Our discussions with investors suggest expectations for the Model 3 ramp that are clearly below the company&apos;s guidance, somewhat de-risking the event path of an official announcement of a further delay.\" id=\"webchat-msg-1414094\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:06pm</span></span><div class=\"messagebody\"><blockquote><p>We&apos;d use further weakness from here as an opportunity to build an Equal-weight position in the stock. Tesla is trading at the midpoint between our base case and bear case valuation. We see Tesla as modestly undervalued with very high risk, particularly for investors who are not comfortable with extreme volatility. We continue to expect that Model 3 production bottlenecks will be mitigated, but we do not expect a 5k/week run-rate before deep into the final quarter of 2018. Our discussions with investors suggest expectations for the Model 3 ramp that are clearly below the company&apos;s guidance, somewhat de-risking the event path of an official announcement of a further delay.</p></blockquote>\n</div></div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522235239\" data-mid=\"1414095\" data-rawmessage=\"For much of the past seven years, Tesla has nearly monopolized Auto 2.0 amongst the publicly traded OEMS. In our opinion, the next seven years may be a far more volatile and crowded narrative. We rate Tesla Equal-weight with a $379 price target.\" id=\"webchat-msg-1414095\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:07pm</span></span><div class=\"messagebody\"><blockquote><p>For much of the past seven years, Tesla has nearly monopolized Auto 2.0 amongst the publicly traded OEMS. In our opinion, the next seven years may be a far more volatile and crowded narrative. We rate Tesla Equal-weight with a $379 price target.</p></blockquote>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\tsorry lapsing into slack  messaging\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@Miss Piggyits still polluting just in someone elses lot. but its  a lack of infrastructure across the spectrum.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\t@arash - any update on SHP?\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Pseudonym</span>\n\t\t\t\t\t\t\t\t@red You can build much more efficient generating plant when it doesn&apos;t have to move at 70mph.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\tre TSLA Anecdotally I am told they are brilliant cars  but that may not be enough\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:08:43.000Z\" title=\"Wed Mar 28 2018 11:08:43 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:08:43 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t12:08 pm\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522235338\" data-mid=\"1414096\" data-rawmessage=\".... oh, and while I remember, Neil Campling of Mirabaud had some thoughts on the NVidia suspension of Herbies overnight, which might or might not have been the catalyst to the FAANGS selloff.\" id=\"webchat-msg-1414096\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:08pm</span></span><div class=\"messagebody\"><p>.... oh, and while I remember, Neil Campling of Mirabaud had some thoughts on the NVidia suspension of Herbies overnight, which might or might not have been the catalyst to the FAANGS selloff.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Puntino</span>\n\t\t\t\t\t\t\t\t@Fatdaz &apos;if you only have to go in a straight line&apos; was the addendum I had.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Grouchmonkey</span>\n\t\t\t\t\t\t\t\t$379? Hm. I&apos;ll make a note of that. Will be v interesting to look back on that prediction in a years&apos; time.\n\t\t\t\t\t\t\t</div><div class=\"msg blockquote has-headshot\" data-timestamp=\"1522235379\" data-mid=\"1414098\" data-rawmessage=\"Because so much has been made about autonomous vehicle (AV) technology improvements, about how disruptive Nvidia&#x2019;s own AV  technology is, about how the auto OEM&#x2019;s are already in survival and panic mode because of the massive disruption from the technology advances. Now, probably for the first time, we have to ask the question ; perhaps, the technology doesn&#x2019;t work? That would have seriously negative implications for the tech complex because much of the recent multiple expansion and &#x201C;tech Cambrian&#x201D; (really??) discussions of late have been about the unstoppable rise of AI and its relationship to the biggest application ever (cars), that machine learning will take over the world and every mile of the planet would soon be driven by level 5 autonomous vehicles.  Whatever your view of datacentre growth there can be no denying that AV&#x2019;s and Nvidia&#x2019;s AV efforts have been a contributing factor behind a stock that has moved from 15x F12M P/E to 45x in three years. The only fair argument for discussion would be about how much it is a factor.\" id=\"webchat-msg-1414098\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:09pm</span></span><div class=\"messagebody\"><blockquote><p>Because so much has been made about autonomous vehicle (AV) technology improvements, about how disruptive Nvidia&#x2019;s own AV  technology is, about how the auto OEM&#x2019;s are already in survival and panic mode because of the massive disruption from the technology advances. Now, probably for the first time, we have to ask the question ; perhaps, the technology doesn&#x2019;t work? That would have seriously negative implications for the tech complex because much of the recent multiple expansion and &#x201C;tech Cambrian&#x201D; (really??) discussions of late have been about the unstoppable rise of AI and its relationship to the biggest application ever (cars), that machine learning will take over the world and every mile of the planet would soon be driven by level 5 autonomous vehicles.  Whatever your view of datacentre growth there can be no denying that AV&#x2019;s and Nvidia&#x2019;s AV efforts have been a contributing factor behind a stock that has moved from 15x F12M P/E to 45x in three years. The only fair argument for discussion would be about how much it is a factor.</p></blockquote>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522235408\" data-mid=\"1414099\" data-rawmessage=\"&quot;What if it doesn&apos;t work&quot; seems to be an under-asked question, I find.\" id=\"webchat-msg-1414099\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:10pm</span></span><div class=\"messagebody\"><p>&quot;What if it doesn&apos;t work&quot; seems to be an under-asked question, I find.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@BE NVidia is at an interesting  junction what with chip  use in crypto mining and autonomous cars\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:10:25.000Z\" title=\"Wed Mar 28 2018 11:10:25 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:10:25 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t12:10 pm\n\t\t\t\t\t\t\t\t</time><div class=\"msg separator has-headshot\" data-timestamp=\"1522235440\" data-mid=\"1414100\" data-rawmessage=\"12:10PM\" id=\"webchat-msg-1414100\">\n\t<div class=\"messagebody\"><time class=\"o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:10:40.000Z\" title=\"Wed Mar 28 2018 11:10:40 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:10:40 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\tundefined\n\t\t\t\t\t\t\t\t</time></div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\t@FATDAZus finds it tough to provide europe with cars they want to buy. i dont think that has changed esp when considering the cost to get it on the road here.\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522235476\" data-mid=\"1414101\" data-rawmessage=\"Right! We&apos;re done. Go here for all your Shire updates: https://www.ft.com/content/6d2e25ae-326a-11e8-ac48-10c6fdc22f03\" id=\"webchat-msg-1414101\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:11pm</span></span><div class=\"messagebody\"><p>Right! We&apos;re done. Go here for all your Shire updates: <a href=\"https://www.ft.com/content/6d2e25ae-326a-11e8-ac48-10c6fdc22f03\" target=\"_blank\">https://www.ft.com...-ac48-10c6fdc22f03</a></p>\n</div></div><div class=\"msg normal has-headshot\" data-timestamp=\"1522235487\" data-mid=\"1414102\" data-rawmessage=\"Or here: https://www.ft.com/content/9688f79e-3265-11e8-ac48-10c6fdc22f03\" id=\"webchat-msg-1414102\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:11pm</span></span><div class=\"messagebody\"><p>Or here: <a href=\"https://www.ft.com/content/9688f79e-3265-11e8-ac48-10c6fdc22f03\" target=\"_blank\">https://www.ft.com...-ac48-10c6fdc22f03</a></p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Grouchmonkey</span>\n\t\t\t\t\t\t\t\t@BE you off to ask it of the FT IT dept?  Thanks all\n\t\t\t\t\t\t\t</div><time class=\"marketslive-timestamp o-date\" data-o-component=\"o-date\" data-o-date-format=\"h:mm a\" datetime=\"2018-03-28T11:11:48.000Z\" title=\"Wed Mar 28 2018 11:11:48 GMT+0000 (UTC)\" aria-label=\"Wed Mar 28 2018 11:11:48 GMT+0000 (UTC)\">\n\t\t\t\t\t\t\t\t\t\t12:11 pm\n\t\t\t\t\t\t\t\t</time><div class=\"msg normal has-headshot\" data-timestamp=\"1522235523\" data-mid=\"1414103\" data-rawmessage=\"Or, I&apos;m sure, a couple of dozen other stories once the mighty FT Response Team get rolling into action.\" id=\"webchat-msg-1414103\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:12pm</span></span><div class=\"messagebody\"><p>Or, I&apos;m sure, a couple of dozen other stories once the mighty FT Response Team get rolling into action.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\t@putino @ red thanks\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tdont think present tech gives a positive answer.\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">GBKrona</span>\n\t\t\t\t\t\t\t\tBrill, thanks @BE, @Arash, ROTR\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Miss Piggy</span>\n\t\t\t\t\t\t\t\tbye\n\t\t\t\t\t\t\t</div><div class=\"msg normal has-headshot\" data-timestamp=\"1522235564\" data-mid=\"1414104\" data-rawmessage=\"Thanks for the comments, all. See you tomorrow.\" id=\"webchat-msg-1414104\">\n\t<span class=\"messageheader\"><span class=\"participant color-1\">BE</span><span class=\"timestamp\">12:12pm</span></span><div class=\"messagebody\"><p>Thanks for the comments, all. See you tomorrow.</p>\n</div></div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">FATDAZ</span>\n\t\t\t\t\t\t\t\tThanks all have a good Easter break\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">J L</span>\n\t\t\t\t\t\t\t\tThanks all..\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">red</span>\n\t\t\t\t\t\t\t\tyes good easter to all\n\t\t\t\t\t\t\t</div>\n\t\t\t\t\t\t\t<div class=\"marketslive-user-comment\">\n\t\t\t\t\t\t\t\t<span class=\"marketslive-user-comment-pseudonym\">Peace and Love</span>\n\t\t\t\t\t\t\t\tMerci pour tout\n\t\t\t\t\t\t\t</div></div>",
  "authors": [
    {
      "concept": {
        "apiUrl": "http://api.ft.com/people/602c702b-31fe-4116-a203-747c7c737eb7",
        "directType": "http://www.ft.com/ontology/person/Person",
        "id": "602c702b-31fe-4116-a203-747c7c737eb7",
        "predicate": "http://www.ft.com/ontology/annotation/hasAuthor",
        "prefLabel": "Bryce Elder",
        "type": "PERSON",
        "types": [
          "http://www.ft.com/ontology/core/Thing",
          "http://www.ft.com/ontology/concept/Concept",
          "http://www.ft.com/ontology/person/Person"
        ],
        "preposition": "from",
        "url": "https://www.ft.com/markets/bryce-elder",
        "relativeUrl": "/markets/bryce-elder"
      },
      "name": "Bryce Elder",
      "headshotUrl": "https://www.ft.com/__origami/service/image/v2/images/raw/fthead:bryce-elder?source=alphaville",
      "isAlphavilleEditor": true,
      "url": "/author/Bryce%20Elder"
    }
  ],
  "primaryTheme": [
    {
      "label": "Markets Live",
      "url": "/marketslive"
    }
  ],
  "originalTitle": "Markets Live: Wednesday, 28th March, 2018",
  "isLive": false,
  "subheading": "Live markets commentary from FT.com",
  "standfirst": "Live markets commentary from FT.com"
}
